MedTrace Logo

Randomized Trial of In-Home Cervical Cancer Screening in Underscreened Women

NCT02005510 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19851

Last updated 2020-09-16

Study results available
· View outcomes & findings →

Summary

The purpose of this trial is to determine whether mailing in-home human papillomavirus (HPV) screening kits is effective in increasing uptake of cervical cancer screening and early detection and treatment of cervical neoplasia in underscreened women.

Conditions

Interventions

BEHAVIORAL

Mailed in-home high-risk HPV testing kit

OTHER

Usual care

Sponsors & Collaborators

  • Kaiser Permanente

    collaborator OTHER

  • University of Texas Southwestern Medical Center

    collaborator OTHER

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of California, Davis

    collaborator OTHER

  • University of Washington

    lead OTHER

Principal Investigators

  • Rachel L Winer, PhD, MPH · University of Washington

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
64 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2018-02-28
Completion
2018-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02005510 on ClinicalTrials.gov